Sitagliptin/Metforminijev Klorid Pharmazac 50 Mg/1000 Mg

Sitagliptin/Metforminijev Klorid Pharmazac 50 mg/1000 mg is a combination oral medication used for type 2 diabetes management. This fixed-dose therapy combines two active ingredients to support blood sugar control. Ideal for adults with diabetes seeking combined treatment options.

Sitagliptin/Metforminijev Klorid Pharmazac 50 mg/1000 mg is used to improve blood sugar levels in adults with type 2 diabetes. It combines metformin, which reduces glucose production in the liver, with sitagliptin, which enhances insulin release after meals. This combination therapy is often prescribed when diet and exercise alone are insufficient.

Sitagliptin/Metforminijev Klorid Pharmazac 50 mg/1000 mg helps maintain steady blood sugar levels throughout the day. Users may notice improved energy levels and reduced symptoms of high blood sugar, such as excessive thirst or frequent urination. Individual responses vary based on diet, activity, and overall health.

Store Sitagliptin/Metforminijev Klorid Pharmazac 50 mg/1000 mg at room temperature, away from moisture and heat. Keep the medication in its original packaging and out of reach of children. Regular blood sugar monitoring is recommended to assess treatment effectiveness and adjust care as needed.

Sitagliptin/Metforminijev Klorid Pharmazac 50 mg/1000 mg may interact with alcohol, which can increase the risk of lactic acidosis. Certain medications, such as diuretics or corticosteroids, may affect blood sugar levels. Always inform your healthcare provider about all medications and supplements you are taking.